Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
出版年份 2015 全文链接
标题
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
作者
关键词
-
出版物
LEUKEMIA
Volume 30, Issue 3, Pages 640-648
出版商
Springer Nature
发表日期
2015-10-21
DOI
10.1038/leu.2015.289
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacologic agents targeting autophagy
- (2015) Helin Vakifahmetoglu-Norberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
- (2015) Jahangir Abdi et al. Oncotarget
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
- (2014) J. Wang et al. BLOOD
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway
- (2014) Yajun Wang et al. TOXICOLOGY
- Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
- (2014) Kim De Veirman et al. Cancers
- An Overview of Autophagy: Morphology, Mechanism, and Regulation
- (2013) Katherine R. Parzych et al. ANTIOXIDANTS & REDOX SIGNALING
- Fibroblast-mediated drug resistance in cancer
- (2013) Kim H.T. Paraiso et al. BIOCHEMICAL PHARMACOLOGY
- Do reciprocal interactions between cell stress proteins and cytokines create a new intra-/extra-cellular signalling nexus?
- (2013) Brian Henderson et al. CELL STRESS & CHAPERONES
- Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
- (2013) M. Moschetta et al. CLINICAL CANCER RESEARCH
- Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
- (2013) Fiorenza Lotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
- (2013) M A Frassanito et al. LEUKEMIA
- Regulation of autophagy by stress-responsive transcription factors
- (2013) Federico Pietrocola et al. SEMINARS IN CANCER BIOLOGY
- Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
- (2013) Shinsaku Togo et al. Cancers
- Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
- (2012) D. J. Kuhn et al. BLOOD
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Cytokine production and inflammation drive autophagy in the tumor microenvironment
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Autophagy and cytokines
- (2011) James Harris CYTOKINE
- Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
- (2011) Amy M. Ruschak et al. JNCI-Journal of the National Cancer Institute
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
- (2011) Mu Hao et al. LEUKEMIA & LYMPHOMA
- The Role of Autophagy in Cancer: Therapeutic Implications
- (2011) Z. J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer
- (2010) Kevin Dalby et al. Autophagy
- Regulation of autophagy by transforming growth factor-β (TGF-β) signaling
- (2010) Hiroshi I. Suzuki et al. Autophagy
- Autophagy in cancer associated fibroblasts promotes tumor cell survival
- (2010) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- mTOR regulation of autophagy
- (2010) Chang Hwa Jung et al. FEBS LETTERS
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models
- (2009) S Deleu et al. LEUKEMIA
- Effect of autophagy on multiple myeloma cell viability
- (2009) B. Hoang et al. MOLECULAR CANCER THERAPEUTICS
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Arsenic trioxide and 2-methoxyestradiol reduce β-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib
- (2008) Lili Zhou et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More